HomePBYI • NASDAQ
add
Puma Biotechnology Inc
Previous close
$2.90
Day range
$2.89 - $3.14
Year range
$2.23 - $7.73
Market cap
147.26M USD
Avg Volume
442.70K
P/E ratio
6.32
Dividend yield
-
Primary exchange
NASDAQ
Market news
MarketWatch
1 day ago
Nvidia and the Magnificent Seven make up too much of your high-priced index
fund
0.35%
3.22%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 80.54M | 43.53% |
Operating expense | 29.37M | -14.25% |
Net income | 20.32M | 250.53% |
Net profit margin | 25.23 | 144.24% |
Earnings per share | 0.45 | 164.71% |
EBITDA | 24.96M | 117.76% |
Effective tax rate | 1.41% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 96.72M | 13.76% |
Total assets | 220.72M | 8.41% |
Total liabilities | 149.63M | -9.24% |
Total equity | 71.09M | — |
Shares outstanding | 49.09M | — |
Price to book | 2.00 | — |
Return on assets | 25.93% | — |
Return on capital | 36.25% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 20.32M | 250.53% |
Cash from operations | 11.04M | 3.98% |
Cash from investing | 259.00K | -97.68% |
Cash from financing | -11.18M | — |
Net change in cash | 114.00K | -99.48% |
Free cash flow | 3.48M | -56.66% |
About
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
Founded
2007
Headquarters
Website
Employees
185
